How to Read Your Testosterone Lab Results: Total T, Free T, SHBG & Hematocrit Explained

You finally got your testosterone labs drawn. Now you're staring at a wall of numbers — Total Testosterone, Free Testosterone, SHBG, Hematocrit, Estradiol, PSA — and you have no idea what any of them mean. Worse, your doctor glanced at the panel for ten seconds and said "everything's normal" despite the fact that you feel terrible.

This happens constantly. The standard reference ranges printed on lab reports are based on population averages that include sick 80-year-olds. "Normal" on a lab report does not mean "optimal." And if you don't understand the difference, you'll get sent home with zero answers.

This guide walks you through every single marker on a comprehensive testosterone panel — what it measures, what optimal actually looks like for your age, and what critical safety markers need to be watched if you start TRT. By the end, you'll be able to read your own labs with clinical-level confidence.

The Core Hormones: Total T vs. Free T vs. Bioavailable T

Most men think testosterone is a single number. It's not. Testosterone exists in three forms in your bloodstream, and understanding all three is essential to evaluating your hormonal health.

Total Testosterone

Total testosterone measures the entire amount of testosterone circulating in your blood — both the portion bound to proteins and the portion floating free. It's the most commonly ordered test and the number you'll see referenced most often. Standard laboratory reference ranges typically fall between 264 and 916 ng/dL (Quest Diagnostics) or 250–1,100 ng/dL (LabCorp), depending on the assay used.

However, Total T alone can be deeply misleading. A man can have a Total T of 450 ng/dL and feel perfectly fine if his SHBG is low and most of that testosterone is bioavailable. Another man with a Total T of 550 ng/dL might be profoundly symptomatic because his SHBG is sky-high and very little of that testosterone is actually reaching his tissues. That's why the next two markers matter enormously.

Free Testosterone

Free testosterone represents the 1–3% of total testosterone that is completely unbound to any protein. This fraction is immediately available to enter cells, bind to androgen receptors, and produce biological effects — from building muscle to maintaining libido to supporting mood and cognition. Many endocrinologists consider free T to be the single most clinically meaningful number on a testosterone panel.

Standard reference ranges for free testosterone via the equilibrium dialysis method are approximately 35–155 pg/mL for adult males, though this varies by age. Most TRT-experienced clinicians consider values below 50 pg/mL to be suboptimal regardless of age, and optimal levels for symptomatic relief tend to fall between 100 and 200 pg/mL.

Bioavailable Testosterone

Bioavailable testosterone includes both free testosterone and the loosely-bound fraction attached to albumin. Albumin-bound testosterone can dissociate relatively easily and become available to tissues, making bioavailable T a broader measure of "usable" testosterone. This typically represents about 30–50% of total testosterone.

While not ordered as routinely as Total T and Free T, bioavailable testosterone (often calculated using the Vermeulen equation) can resolve ambiguous cases where Total T looks adequate but the patient is clearly symptomatic. Optimal bioavailable T generally falls between 145 and 400 ng/dL for men under 50.

SHBG: The Hidden Variable That Changes Everything

Sex Hormone-Binding Globulin (SHBG) is a protein produced primarily by the liver that binds tightly to testosterone and renders it biologically inactive. Roughly 60–70% of your total testosterone is locked up by SHBG at any given time. The remaining testosterone is either loosely bound to albumin or circulating free.

SHBG is arguably the most underappreciated marker on a testosterone panel. Two men with identical Total T values can have drastically different symptom profiles based solely on SHBG levels:

• High SHBG (above 50 nmol/L): Sequesters more testosterone, lowering the free fraction. Common causes include aging, liver disease, hyperthyroidism, and use of certain medications (anticonvulsants, some SSRIs). Men with high SHBG often have "normal" Total T but are deeply symptomatic.
• Low SHBG (below 20 nmol/L): Releases more testosterone into the free fraction. Common causes include obesity, insulin resistance, type 2 diabetes, and hypothyroidism. Low SHBG can inflate Free T relative to Total T, but it often signals underlying metabolic dysfunction.
• Optimal SHBG range: Most clinicians target 20–50 nmol/L. The sweet spot for most men on TRT is around 25–40 nmol/L.

SHBG also matters for TRT dosing strategy. Men with high SHBG often do better on more frequent injection schedules (e.g., every-other-day micro-dosing) because it prevents SHBG from "gobbling up" testosterone during peak levels after injection. This is one reason why dialing in TRT dosage requires more than just following a cookie-cutter protocol.

What "Normal" Actually Means by Age Decade

The ranges printed on your lab report don't tell the full story. They represent the 2.5th to 97.5th percentile of the entire tested population — which includes both healthy 25-year-olds and 85-year-olds with multiple chronic conditions. Here's what age-stratified data from the Framingham Heart Study, the Baltimore Longitudinal Study of Aging, and large-scale Quest Diagnostics population data actually show:

Data synthesized from Travison et al. (2007), Kelsey et al. (2014), and the Massachusetts Male Aging Study. SHBG increases roughly 1–2% per year after age 30, which means Free T declines faster than Total T.

The key takeaway: a Total T of 350 ng/dL might be "within range" on your lab printout, but for a 35-year-old man, that's in the bottom 5th percentile of his age cohort. That context matters. This is exactly why clinicians at Telehealth FX interpret your results within the context of age, symptoms, and the full hormonal panel — not just a single reference range.

Estradiol (E2): The Testosterone Metabolite You Must Track

Testosterone doesn't just stay as testosterone. A portion of it gets converted to estradiol (E2) via the aromatase enzyme, particularly in adipose (fat) tissue. Estradiol is essential for men — it protects bones, supports cardiovascular health, and contributes to cognitive function. But too much or too little creates real problems.

The standard lab reference range for male estradiol via the sensitive LC-MS/MS assay is roughly 8–35 pg/mL. However, clinicians managing TRT patients generally aim for a functional target of 20–35 pg/mL. Here's what happens at the extremes:

• High E2 (above 40 pg/mL): Water retention, bloating, nipple sensitivity or gynecomastia, mood swings, decreased libido, erectile difficulty, and elevated blood pressure. This is more common in men with higher body fat percentages, as more aromatase activity occurs in adipose tissue.
• Low E2 (below 15 pg/mL): Joint pain and stiffness, dry skin, low libido (paradoxically), fatigue, depression, and long-term bone density loss. Overly aggressive use of aromatase inhibitors (AIs) is a common culprit — this is one reason modern TRT protocols have largely moved away from routine AI use.

If your estradiol is elevated, the first-line intervention isn't always medication. Reducing body fat, increasing injection frequency (which lowers peak testosterone spikes and thus peak aromatization), and adjusting the dose are all effective strategies. For men on TRT who are also working on body recomposition, estradiol often self-corrects as visceral fat decreases.

Hematocrit & Hemoglobin: The Critical Safety Markers

Testosterone is a potent stimulator of erythropoiesis — red blood cell production. This is a normal physiological response (it's one reason men naturally have higher red blood cell counts than women). But on TRT, this effect can overshoot, and that's when it becomes clinically important.

Hematocrit (HCT) measures the percentage of your blood volume occupied by red blood cells. Hemoglobin (HGB) measures the oxygen-carrying protein within those cells. They track closely together, and both are essential to monitor:

The clinical concern with elevated hematocrit is blood viscosity. When HCT exceeds 54%, blood becomes measurably thicker, increasing shear stress on arterial walls and raising the risk of thromboembolic events — particularly venous thromboembolism (VTE). The Endocrine Society's 2018 clinical practice guidelines recommend holding testosterone therapy if HCT exceeds 54% and resuming only after it has normalized, typically via therapeutic phlebotomy (blood donation).

This is one of the most important reasons TRT requires regular lab monitoring, and it's a core part of the protocol at Telehealth FX. Providers who prescribe testosterone without monitoring hematocrit are putting patients at unnecessary risk. For more on managing cardiovascular safety on TRT, see our detailed guide.

PSA: Prostate-Specific Antigen

PSA (Prostate-Specific Antigen) is a protein produced by prostate cells. Elevated PSA levels can indicate benign prostatic hyperplasia (BPH), prostatitis (inflammation), or, less commonly, prostate cancer. Baseline PSA should be drawn before starting TRT and rechecked at 3–6 months, then annually.

Key clinical thresholds for PSA on TRT:

• Age 40–49: Normal baseline typically <2.5 ng/mL
• Age 50–59: Normal baseline typically <3.5 ng/mL
• Age 60–69: Normal baseline typically <4.5 ng/mL
• Concerning change on TRT: A rise of >1.4 ng/mL within 12 months of initiating therapy warrants urological referral — even if the absolute value remains "within range."

It's important to understand that TRT does not cause prostate cancer. The landmark "saturation model" work by Abraham Morgentaler, M.D. at Harvard demonstrated that once androgen receptors in prostate tissue are saturated (which occurs at serum testosterone levels of approximately 250 ng/dL), additional testosterone does not further stimulate prostate growth. TRT brings testosterone from low to physiological — a range where prostate tissue is already saturated. Nonetheless, PSA monitoring remains standard-of-care because TRT can accelerate the growth of pre-existing (previously undetected) prostate cancer.

Liver Function: AST, ALT, and Lipids

Although injectable and transdermal testosterone have minimal hepatotoxicity (unlike oral 17-alpha-alkylated steroids), monitoring liver enzymes is still important during the first six months of TRT:

• AST (Aspartate Aminotransferase): Normal range 10–40 U/L. Elevation can indicate liver stress but also occurs with intense exercise (skeletal muscle breakdown releases AST).
• ALT (Alanine Aminotransferase): Normal range 7–56 U/L. More liver-specific than AST. A persistent ALT above 2x the upper limit of normal warrants further investigation.
• GGT (Gamma-Glutamyl Transferase): Normal range 9–48 U/L. Useful for distinguishing liver-related ALT/AST elevations from muscle-related ones, especially in men who train heavily.

Lipid Panel on TRT

Testosterone can modestly lower HDL cholesterol (the "good" cholesterol) by 5–10%, particularly at supraphysiologic doses. This is a dose-dependent effect and generally clinically insignificant at therapeutic replacement levels. A complete lipid panel — including Total Cholesterol, LDL, HDL, Triglycerides, and ideally an ApoB level — should be drawn at baseline and rechecked every 6–12 months. Men with pre-existing dyslipidemia or cardiovascular risk factors should discuss statin therapy with their clinician independently of TRT decisions.

Additional Markers: Prolactin, LH, FSH, Thyroid

LH and FSH

Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are pituitary hormones that signal the testes to produce testosterone and sperm, respectively. These are critical for the initial diagnostic workup:

• Low T + Low LH/FSH: Indicates secondary hypogonadism — the problem is in the pituitary or hypothalamus, not the testes. This warrants MRI to rule out pituitary adenoma and may respond to clomiphene citrate or enclomiphene therapy as alternatives to testosterone.
• Low T + High LH/FSH: Indicates primary hypogonadism — the testes aren't responding to pituitary signals. TRT is the appropriate treatment.

Once a patient is on exogenous testosterone, LH and FSH will be suppressed to near zero. This is expected. It also means that spermatogenesis is suppressed — an important consideration for men concerned about fertility while on TRT.

Prolactin

Prolactin is a pituitary hormone that, when elevated in men, can cause low libido, erectile dysfunction, gynecomastia, and fatigue. Normal range is 2–18 ng/mL. Values above 25 ng/mL warrant repeat testing and further workup. Prolactin above 100 ng/mL is highly suspicious for pituitary prolactinoma and requires MRI. Baseline prolactin should be included in pre-TRT labs.

Thyroid Panel (TSH, Free T3, Free T4)

Hypothyroidism mimics many symptoms of low testosterone — fatigue, weight gain, brain fog, depression, and low libido. A basic thyroid screen (at minimum TSH) should be part of any initial hormone evaluation to rule out thyroid dysfunction as a confounding or contributing factor. Normal TSH is 0.4–4.0 mIU/L, though many functional medicine practitioners consider optimal to be 0.5–2.5 mIU/L. Recognizing the signs of low testosterone versus thyroid dysfunction requires examining the full picture.

The Complete TRT Monitoring Schedule

Once you start TRT, lab monitoring isn't a one-time event. The Endocrine Society, the American Urological Association, and the AACE all recommend structured follow-up testing. Here's the evidence-based schedule used by experienced TRT clinicians:

Labs should be drawn in the morning (before 10 AM) and ideally at trough — meaning the day of or day before your next injection. This gives the most clinically actionable data. Post-injection peaks can be misleadingly high and don't reflect steady-state levels.

How to Interpret Your Results: A Step-by-Step Framework

When you get your labs back, here's the systematic approach experienced TRT clinicians use:

1. Check Total T at trough. Is it in the 600–900 ng/dL range (the typical on-TRT target)? If below 500, the dose may need adjustment. If above 1,100, the dose is likely too high.
2. Check Free T. Is it above 100 pg/mL? If Total T looks good but Free T is low, high SHBG may be binding too much testosterone. Increasing injection frequency often helps.
3. Check Estradiol. Is it between 20–35 pg/mL? If above 40, consider reducing dose, losing body fat, or increasing injection frequency before reaching for an AI.
4. Check Hematocrit. Is it below 52%? If it's creeping above 52%, increase hydration, consider lowering dose, and discuss therapeutic phlebotomy. If above 54%, TRT should be paused.
5. Check PSA trend. Has it risen more than 1.4 ng/mL in the past 12 months? If yes, refer to urology. If stable, continue monitoring.
6. Check Lipids. Has HDL dropped significantly? If so, ensure cardiovascular risk is being managed holistically.
7. Correlate with symptoms. The most important "lab" is how you feel. If labs look optimal but symptoms persist, investigate sleep quality, thyroid, cortisol, and lifestyle factors.

Common Lab Mistakes and Misinterpretations

Even experienced patients and some providers make these errors:

• Drawing labs at the wrong time. Post-injection peaks (especially 24–48 hours after an IM injection of cypionate) can produce falsely elevated Total T values. Always draw at trough.
• Using immunoassay for Free T. The direct analog immunoassay for free testosterone is notoriously inaccurate. Equilibrium dialysis (ED) or calculated free T (using the Vermeulen equation based on Total T, SHBG, and albumin) are the gold standards.
• Using the standard immunoassay for estradiol. The standard E2 assay cross-reacts with CRP and other compounds. Always request the sensitive estradiol assay (LC-MS/MS method) for men.
• Ignoring symptoms when labs are "normal." If a man has a Total T of 320 ng/dL and classic hypogonadal symptoms, the fact that 320 falls within the lab's printed range (264–916) does not mean he doesn't need treatment. Symptom correlation is essential.
• Not testing SHBG. Without SHBG, you cannot accurately assess the free testosterone fraction. Any provider managing testosterone without ordering SHBG is missing critical context.

Frequently Asked Questions

What time of day should I get my testosterone blood draw?

Before 10 AM, fasting. Testosterone follows a diurnal rhythm and peaks in the early morning. Afternoon draws can underestimate your actual levels by 20–30%. If you're on TRT, draw at trough — ideally the morning of your next scheduled injection.

My Total T is "normal" but I still feel terrible. Why?

Most likely your Free T is low due to elevated SHBG, or your estradiol is out of range. A Total T of 400 ng/dL with an SHBG of 65 nmol/L would give you a calculated free testosterone well below the optimal threshold. You need the full panel — not just Total T — to get the complete picture.

How often should I get labs on TRT?

At minimum: 6–8 weeks after starting or changing a dose, then every 3–6 months for the first year, then annually once stable. Hematocrit should be checked at every draw without exception.

Does TRT affect my thyroid levels?

TRT can increase thyroid-binding globulin slightly, which may affect total thyroid hormone readings but generally does not change free thyroid hormone levels or clinical thyroid function. If you have hypothyroidism, continue thyroid medication management independently.

What's the difference between LabCorp and Quest testosterone reference ranges?

LabCorp uses the LC-MS/MS method with a reference range of 264–916 ng/dL for total testosterone. Quest Diagnostics uses a similar methodology but may report slightly different ranges (250–1,100 ng/dL) depending on the assay generation. The key is consistency — always use the same lab for serial monitoring so you're comparing apples to apples.